- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00098124
Study of Milnacipran for the Treatment of Fibromyalgia
18. december 2007 opdateret af: Forest Laboratories
A Phase III Pivotal, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Milnacipran for the Treatment of Fibromyalgia
Antidepressants of all varieties represent a common form of therapy for many chronic states including fibromyalgia.
The majority of antidepressants increase the levels of serotonin or norepinephrine in the central nervous system.
Milnacipran is a dual norepinephrine and serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Undersøgelsestype
Interventionel
Tilmelding
1200
Fase
- Fase 3
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35205
- Forest Investigative Site
-
Mobile, Alabama, Forenede Stater, 36608
- Forest Investigative Site
-
Montgomery, Alabama, Forenede Stater, 36111
- Forest Investigative Site
-
-
Arizona
-
Peoria, Arizona, Forenede Stater, 85381
- Forest Investigative Site
-
-
California
-
Beverly Hills, California, Forenede Stater, 90211
- Forest Investigative Site
-
Sacramento, California, Forenede Stater, 95825
- Forest Investigative Site
-
San Diego, California, Forenede Stater, 92117
- Forest Investigative Site
-
San Diego, California, Forenede Stater, 92108
- Forest Investigative Site
-
Santa Ana, California, Forenede Stater, 92705
- Forest Investigative Site
-
Spring Valley, California, Forenede Stater, 91978
- Forest Investigative Site
-
Torrance, California, Forenede Stater, 90505
- Forest Investigative Site
-
-
Colorado
-
Colorado Springs, Colorado, Forenede Stater, 80909
- Forest Investigative Site
-
Colorado Springs, Colorado, Forenede Stater, 80910
- Forest Investigative Site
-
-
Connecticut
-
Danbury, Connecticut, Forenede Stater, 06810
- Forest Investigative Site
-
Stamford, Connecticut, Forenede Stater, 06905
- Forest Investigative Site
-
Trumball, Connecticut, Forenede Stater, 06611
- Forest Investigative Site
-
-
Florida
-
Clearwater, Florida, Forenede Stater, 33761
- Forest Investigative Site
-
Deland, Florida, Forenede Stater, 32720
- Forest Investigative Site
-
Delray Beach, Florida, Forenede Stater, 33484
- Forest Investigative Site
-
Jacksonville, Florida, Forenede Stater, 33216
- Forest Investigative Site
-
Ocala, Florida, Forenede Stater, 34471
- Forest Investigative Site
-
Ormond Beach, Florida, Forenede Stater, 32174
- Forest Investigative Site
-
Palm Harbor, Florida, Forenede Stater, 34684
- Forest Investigative Site
-
Pembroke Pines, Florida, Forenede Stater, 33029
- Forest Investigative Site
-
Port Orange, Florida, Forenede Stater, 32127
- Forest Investigative Site
-
Tamarac, Florida, Forenede Stater, 33321
- Forest Investigative Site
-
-
Georgia
-
Decatur, Georgia, Forenede Stater, 30033
- Forest Investigative Site
-
-
Hawaii
-
Honolulu, Hawaii, Forenede Stater, 96814
- Forest Investigative Site
-
-
Idaho
-
Meridian, Idaho, Forenede Stater, 83642
- Forest Investigative Site
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60612
- Forest Investigative Site
-
Libertyville, Illinois, Forenede Stater, 60048
- Forest Investigative Site
-
Peoria, Illinois, Forenede Stater, 61614
- Forest Investigative Site
-
-
Indiana
-
Evansville, Indiana, Forenede Stater, 47713
- Forest Investigative Site
-
Lafayette, Indiana, Forenede Stater, 47904
- Forest Investigative Site
-
-
Kansas
-
Wichita, Kansas, Forenede Stater, 67207
- Forest Investigative Site
-
-
Kentucky
-
Lexington, Kentucky, Forenede Stater, 40509
- Forest Investigative Site
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21237
- Forest Investigative Site
-
Columbia, Maryland, Forenede Stater, 21045
- Forest Investigative Site
-
Frederick, Maryland, Forenede Stater, 21702
- Forest Investigative Site
-
-
Massachusetts
-
Newton, Massachusetts, Forenede Stater, 02462
- Forest Investigative Site
-
North Dartmouth, Massachusetts, Forenede Stater, 02747
- Forest Investigative Site
-
-
Michigan
-
Kalamazoo, Michigan, Forenede Stater, 49009
- Forest Investigative Site
-
-
Mississippi
-
Flowood, Mississippi, Forenede Stater, 39232
- Forest Investigative Site
-
-
Missouri
-
St. Louis, Missouri, Forenede Stater, 63141
- Forest Investigative Site
-
-
Montana
-
Missoula, Montana, Forenede Stater, 59802
- Forest Investigative Site
-
-
New Jersey
-
Cherry Hill, New Jersey, Forenede Stater, 08002
- Forest Investigative Site
-
Clementon, New Jersey, Forenede Stater, 08021
- Forest Investigative Site
-
-
New Mexico
-
Santa Fe, New Mexico, Forenede Stater, 87505
- Forest Investigative Site
-
-
New York
-
East Syracuse, New York, Forenede Stater, 13057
- Forest Investigative Site
-
Great Neck, New York, Forenede Stater, 11021
- Forest Investigative Site
-
Rochester, New York, Forenede Stater, 14618
- Forest Investigative Site
-
-
North Carolina
-
Charlotte, North Carolina, Forenede Stater, 28209
- Forest Investigative Site
-
Fayetteville, North Carolina, Forenede Stater, 28304
- Forest Investigative Site
-
Hickory, North Carolina, Forenede Stater, 28601
- Forest Investigative Site
-
Raleigh, North Carolina, Forenede Stater, 27612
- Forest Investigative Site
-
Raleigh, North Carolina, Forenede Stater, 27609
- Forest Investigative Site
-
Winston-Salem, North Carolina, Forenede Stater, 27103
- Forest Investigative Site
-
-
North Dakota
-
Bismarck, North Dakota, Forenede Stater, 58501
- Forest Investigative Site
-
-
Ohio
-
Marion, Ohio, Forenede Stater, 43302
- Forest Investigative Site
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Forenede Stater, 73112
- Forest Investigative Site
-
-
Oregon
-
Bend, Oregon, Forenede Stater, 97701
- Forest Investigative Site
-
Eugene, Oregon, Forenede Stater, 97404
- Forest Investigative Site
-
Medford, Oregon, Forenede Stater, 97504
- Forest Investigative Site
-
Portland, Oregon, Forenede Stater, 97205
- Forest Investigative Site
-
-
Pennsylvania
-
Duncanville, Pennsylvania, Forenede Stater, 16635
- Forest Investigative Site
-
-
Rhode Island
-
Warwick, Rhode Island, Forenede Stater, 02886
- Forest Investigative Site
-
-
South Carolina
-
Orangeburg, South Carolina, Forenede Stater, 29118
- Forest Investigative Site
-
-
Tennessee
-
Bristol, Tennessee, Forenede Stater, 37620
- Forest Investigative Site
-
Chattanooga, Tennessee, Forenede Stater, 37404
- Forest Investigative Site
-
Memphis, Tennessee, Forenede Stater, 38119
- Forest Investigative Site
-
-
Texas
-
Austin, Texas, Forenede Stater, 78705
- Forest Investigative Site
-
San Antonio, Texas, Forenede Stater, 78205
- Forest Investigative Site
-
Sugarland, Texas, Forenede Stater, 77479
- Forest Investigative Site
-
-
Virginia
-
Richmond, Virginia, Forenede Stater, 23294
- Forest Investigative Site
-
Virginia Beach, Virginia, Forenede Stater, 23454
- Forest Investigative Site
-
-
Washington
-
Bellingham, Washington, Forenede Stater, 98226
- Forest Investigative Site
-
Everett, Washington, Forenede Stater, 98201
- Forest Investigative Site
-
Seattle, Washington, Forenede Stater, 98166
- Forest Investigative Site
-
Wenatchee, Washington, Forenede Stater, 98801
- Forest Investigative Site
-
-
Wisconsin
-
Racine, Wisconsin, Forenede Stater, 53406
- Forest Investigative Site
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år til 70 år (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria
Exclusion Criteria:
- Psychiatric illness
- Depression
- Suicidal risk
- Substance abuse
- Pulmonary dysfunction
- Renal impairment
- Active cardiac disease
- Liver disease
- Autoimmune disease
- Cancer
- Sleep apnea
- Inflammatory bowel disease
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
---|
Composite responder analysis based on pain and patient global status, with or without physical function.
|
Sekundære resultatmål
Resultatmål |
---|
Livskvalitet
|
Health Assessment Questionnaire (HAQ) Disability Index
|
Fatigue, sleep and cognitive assessments
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. november 2004
Studieafslutning
1. december 2006
Datoer for studieregistrering
Først indsendt
3. december 2004
Først indsendt, der opfyldte QC-kriterier
3. december 2004
Først opslået (Skøn)
6. december 2004
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
24. december 2007
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
18. december 2007
Sidst verificeret
1. december 2007
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Sygdomme i nervesystemet
- Muskuloskeletale sygdomme
- Reumatiske sygdomme
- Muskelsygdomme
- Neuromuskulære sygdomme
- Fibromyalgi
- Myofasciale smertesyndromer
- Lægemidlers fysiologiske virkninger
- Neurotransmittermidler
- Molekylære mekanismer for farmakologisk virkning
- Agenter fra det perifere nervesystem
- Analgetika
- Sensoriske systemagenter
- Analgetika, ikke-narkotisk
- Psykotropiske stoffer
- Neurotransmitter optagelseshæmmere
- Membrantransportmodulatorer
- Antidepressive midler
- Serotonin- og Noradrenalin-genoptagelseshæmmere
- Milnacipran
- Levomilnacipran
Andre undersøgelses-id-numre
- MLN-MD-02
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med milnacipran hydrochloride
-
Forest LaboratoriesCypress Bioscience, Inc.Afsluttet
-
Indiana UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases...Afsluttet
-
Pierre Fabre MedicamentAfsluttetFibromyalgi syndromSpanien, Italien, Portugal, Frankrig, Tjekkiet, Finland, Tyskland, Norge, Rumænien, Sverige, Danmark, Polen, Det Forenede Kongerige
-
Chang Gung Memorial HospitalUkendtDepression | Iskæmisk slagtilfældeTaiwan
-
Pierre Fabre MedicamentAfsluttetFibromyalgi syndromSpanien, Italien, Portugal, Frankrig, Tjekkiet, Finland, Tyskland, Norge, Rumænien, Sverige
-
California Medical Clinic for HeadacheUkendtKronisk migræne | Migræne uden aura | Migræne med AuraForenede Stater
-
Dr. Norman HardenForest LaboratoriesAfsluttetKronisk smerte | Knæ slidgigt | Degenerativ ledsygdom
-
Duke UniversityAfsluttetSlidgigt Smerter | Knæsmerter efter total knæarthroplastikForenede Stater
-
Valera BussellForest LaboratoriesAfsluttet
-
Forest LaboratoriesCypress Bioscience, Inc.Afsluttet